VTAK Catheter Precision, Inc.

NEUTRAL Impact: 3/10 PRESS-RELEASE
Horizon weeks Filed Jun 8, 2026 Processed 8d 22h ago Wire GlobeNewswire
Press release: announcement
Latest settled — T+5d ⚠ clustered
VTAK ▲ +2.94% at T+5d
NEUTRAL call ✓ call won +2.94% · α vs SPY +0.83% · entry $1.02 → $1.05
Next anchor: T+20d in 20d
Currently $0.9800 · -3.92% from $1.02 entry
Entry anchored
Jun 5, 03:22 PM ET
via Databento tick
T+1d
-2.25%
call -2.25% · α -1.95%
$0.9971
settled 8d ago
T+5d
+2.94%
call +2.94% · α +0.83%
$1.05
settled 2d ago
T+20d
call — · α —
in 20d
T+60d
call — · α —
in 3mo

Price Chart

Loading chart...

Executive Summary

Catheter Precision (VTAK) subsidiary Flyte acquired ~2.9 million shares of Volato Group (SOAR), representing a ~7.5% stake. This is a small strategic investment in a different aviation-tech company, not a transformative event for VTAK given its ~$3M market cap.

Actionable Insight

The deal lacks hard financial details and is unlikely to move VTAK's stock materially given its tiny market cap and non-core nature. Watch for the 8-K filing for deal terms and any cash impact.

Key Facts

  • Flyte (subsidiary of VTAK) acquired ~2.9M shares of SOAR for a ~7.5% ownership stake
  • Transaction supports Flyte's strategy to expand aviation ecosystem and seek partnerships
  • Investment provides growth capital and a strategic shareholder for SOAR
  • Deal size not disclosed; VTAK market cap is ~$3M, so any material cash outlay could be significant relative to its size

Financial Impact

Undisclosed amount. ~2.9M shares of SOAR acquired; VTAK market cap is ~$3M, so relative impact could be material if cash consideration was large, but no dollar amount provided.

cashinvestmentsstrategic positioning

Risk Factors

  • No financial terms disclosed, making it impossible to assess economic impact
  • VTAK is a medical device company investing in aviation — a significant strategic pivot that may dilute focus
  • Both companies have micro-cap profiles (~$3M and potentially similar), amplifying execution risk

Market Snapshot

Exchange
NYSE
Sector
Surgical & Medical Instruments & Apparatus
Analyst Consensus
86% bullish (7 analysts)

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3308266
11 reports for VTAK
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for VTAK — sortable, filterable
Type Now
Jun 8, 2026
8d ago
Press Release
NEUTRAL ★ 3/10
$1.02 $1.05▲ +2.94%▲ +0.83%$0.9800 (−3.92%)
Jun 8, 2026
9d ago
8-K
NEUTRAL ★ 4/10
$1.02 $1.05▲ +2.94%▲ +0.83%$0.9800 (−3.92%)
May 4, 2026
6w ago
Press Release
NEUTRAL ★ 2/10
$0.9400 $0.8100▼ −13.83%▼ −16.77%$0.9800 (+4.26%)
Apr 21, 2026
8w ago
Press Release
BULLISH ★ 6/10
$0.9500 $0.9300▼ −2.11%▼ −3.19%$0.9800 (+3.16%)
Apr 20, 2026
8w ago
Press Release
NEUTRAL ★ 4/10
$0.9800 $0.9000▼ −8.16%▼ −9.08%$0.9800 (+0.00%)
Apr 8, 2026
10w ago
Press Release
NEUTRAL ★ 3/10
$0.8600 $1.03▲ +19.77%▲ +16.25%$0.9800 (+13.95%)
Apr 6, 2026
10w ago
Press Release
NEUTRAL ★ 4/10
$0.9500 $1.22▲ +28.42%▲ +24.29%$0.9800 (+3.16%)
Mar 31, 2026
11w ago
8-K
MIXED ★ 6/10
$0.9400 $1.21▲ +28.72%▲ +24.96%$0.9800 (+4.26%)
Mar 31, 2026
11w ago
Press Release
MIXED ★ 6/10
$1.01 $0.8600▼ −14.85%▼ −18.80%$0.9800 (−2.97%)
Mar 23, 2026
12w ago
DEFA14A
BEARISH ★ 7/10
$1.20 $1.01▲ +15.83%▲ +15.41%$0.9800 (+18.33%)
Showing 10 of 11

US Market Status

Market Closed — Opens in 28m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access